Santosh Annasaheb Chindhe
About Santosh Annasaheb Chindhe
Data last updated:
Santosh Annasaheb Chindhe is a Director at Chemicea Pharmaceuticals Private Limited (since 2016) and Director at Chemicea Global Private Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Chemicea Pharmaceuticals Private Limited at ₹7.88 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chemicea Pharmaceuticals Private Limited U24290MH2016PTC402262 | Director | 21 Jul 2016 | 2016 | ₹7.88 Cr (FY 2024) | Active |
 Chemicea Global Private Limited U46497MR2026PTC481307 | Director | 29 Sep 2026 | 2026 | Active |
Board colleagues of Santosh Annasaheb Chindhe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Kadu Pawar | 07519284 | Chemicea Pharmaceuticals Private Limited , Chemicea Global Private Limited | Director |
| Samir Subhash Kadam | 11977094 | Chemicea Global Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Annasaheb Chindhe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Annasaheb Chindhe
Santosh Annasaheb Chindhe currently holds 2 directorships: Chemicea Pharmaceuticals Private Limited (Director, since 21 Jul 2016, revenue ₹7.88 Cr (FY 2024)); Chemicea Global Private Limited (Director, since 29 Sep 2026).
Santosh Annasaheb Chindhe was first appointed on 21 Jul 2016 as Director at Chemicea Pharmaceuticals Private Limited. The most recent appointment on record is 29 Sep 2026 at Chemicea Global Private Limited.
The current boards of Santosh Annasaheb Chindhe's companies include Deepak Kadu Pawar (Chemicea Pharmaceuticals Private Limited), Samir Subhash Kadam (Chemicea Global Private Limited).